Gsk Share Discussion Threads

[essentialinvestor] 30/1/2017 13:12

Gary you got the very same price as me, trade time was 8.23.

[garycook] 30/1/2017 13:05

Purchased earlier this morning at 15.1576.Could not resist it.Now recovered also,so it was a good entry point.With good results next week,GSK could be back to £16,witin the next month or so.

[essentialinvestor] 30/1/2017 08:28

Another few.

[garycook] 27/1/2017 13:04

GSK,struggling with AZN,and SHP.Pharma seems out of fashion atm.

[essentialinvestor] 27/1/2017 12:43

ViiV's duel compound is going to take market share.
Not sure are if they running a further Phase 111 or just going straight for
submission.

[tradermichael] 27/1/2017 11:46

Can't see those levels returning as long as the £ vs $ is so weak. GSK earnings will be very strong when final results are reported (due 8 Feb 2017)...... ;0)

[essentialinvestor] 27/1/2017 11:44

Around 14.60?, possible, that's a great longer term price unless we get
poor news flow or wider markets tank.

[garycook] 27/1/2017 11:40

Sure,Want to buy for my son,s ISA,but looking at £15 or a bit lower.Currently range bound in the 1518/1535.Just have a feeling we could retrace back to early December levels.

[essentialinvestor] 27/1/2017 11:34

Often a couple of days after the XD is a decent time to add,
will not always work like that.

[garycook] 27/1/2017 11:32

Will the share price drop 23p or more next XD ? Which XD last year,did we not get a drop ?

[essentialinvestor] 27/1/2017 11:27

Lower would be lovely Michael so looking for another drop.

[tradermichael] 27/1/2017 11:17

Me also - IN @1523p ......;0)

[essentialinvestor] 27/1/2017 10:40

Added another few this AM.

[philanderer] 25/1/2017 19:45

GlaxoSmithKline PLC (NYSE:GSK) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday. The firm currently has a $44.00 price target on the pharmaceutical company’s stock.

[mj19] 24/1/2017 22:39

GlaxoSmithKline plc logoGlaxoSmithKline plc (LON:GSK) had its price objective hoisted by Deutsche Bank AG from GBX 1,760 ($21.96) to GBX 1,800 ($22.46) in a research report sent to investors on Thursday. The firm currently has a hold rating on the stock.GSK has been the subject of a number of other reports. Jefferies Group increased their price target on GlaxoSmithKline plc from GBX 1,900 ($23.71) to GBX 1,950 ($24.34) and gave the stock a buy rating in a report on Thursday, October 13th. Citigroup Inc. reiterated a buy rating and set a GBX 1,800 ($22.46) price target on shares of GlaxoSmithKline plc in a report on Wednesday, October 5th. Bryan, Garnier & Co reiterated a buy rating on shares of GlaxoSmithKline plc in a report on Monday, October 17th. Sanford C. Bernstein set a GBX 1,834 ($22.89) price target on GlaxoSmithKline plc and gave the stock a neutral rating in a report on Wednesday, October 19th. Finally, JPMorgan Chase & Co. reiterated a neutral rating and set a GBX 1,667 ($20.80) price target on shares of GlaxoSmithKline plc in a report on Wednesday, October 19th. Two investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and nine have given a buy rating to the stock. The stock currently has a consensus rating of Hold and a consensus target price of GBX 1,729.78 ($21.59).

[toffeeman] 24/1/2017 19:39

Inverse H&S anyone?

[essentialinvestor] 24/1/2017 19:26

The entire sector looks weak stateside atm, the Trump post inaugural bump.

Growing power of the major US insurers looks the main US headwind imv,
GSK have flagged this up numerous times already.

Everyone is focussed on Trump and what may and may not be, but price pressure
from insurers is happening now. GSK's model looks well placed to cope,
however would expect Emma to announce a further round of restructuring this year.

[mj19] 24/1/2017 19:21

Seems cheap but not up in the US

[essentialinvestor] 24/1/2017 16:11

Added a few.

[essentialinvestor] 24/1/2017 15:57

Sector very weak stateside in early trading.

[ny boy] 24/1/2017 10:33

EssI Anyone should only ever buy what they can comfortably afford for one stock. I only bought a few grands worth, it's enough for me. GL with your holding

[philanderer] 24/1/2017 10:33

GlaxoSmithKline : *GOLDMAN RAISES GLAXOSMITHKLINE PRICE TARGET TO 1850 PENCE - 'BUY'


01/24/2017 | 07:10am CET

[essentialinvestor] 24/1/2017 09:02

NY, my BT.A buy is only a few hundred shares, could not bring myself to buy
anymore.

[ny boy] 24/1/2017 08:58

Defensive qualities, too cheap imho

Tks Essential

Bought a few BT.A on the 20% dip this morning, just to tuck away for the pension fund

[tradermichael] 24/1/2017 08:44

A month to go 'til next ex. dividend (23 Feb). Amazing how quickly it comes around ..... ;0)